Vertex to end sales of hepatitis C drug Incivek

(Reuters) - Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its Incivek hepatitis C treatment, whose use has been largely supplanted by the new Sovaldi drug from Gilead Sciences Inc.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news